Evidence map›Paper›PMID 36625102›Full record

ReviewAnalytical chemistry2023

NMR Metabolomics Methods for Investigating Disease.

G A Nagana Gowda, Daniel Raftery

Abstract readReview
In one paragraph

Review in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Analytical greenness metrics for metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Protomix: a Python package forBioinformatics advances · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Molecules, Up Your Spins!Molecules (Basel, Switzerland) · 2024
    Article
  20. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.Journal of experimental & clinical cancer research : CR · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel RafteryFred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States.ORCID 0000-0003-2467-8118

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI GREGORY J MORTON · 1986 to 2026
$30.4M
UW Center for Translational Muscle Research (Overall Application)P30AR074990 · NIAMS · UNIVERSITY OF WASHINGTON · PI Jennifer Michelle Davis, DANIEL RAFTERY · 2019 to 2026
$7.5M
Modeling Homeostasis of Human Blood MetabolitesR01GM131491 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAFTERY, DANIEL, ZHANG, DABAO · 2020 to 2023
$2.2M
Quantitative Analysis of Labile Metabolites in Biological SamplesR01GM138465 · NIGMS · UNIVERSITY OF WASHINGTON · PI GOWDA, G. A. NAGANA, RAFTERY, DANIEL · 2021 to 2024
$1.5M
NCI NIH HHS P30 CA015704NIAMS NIH HHS P30 AR074990NIDDK NIH HHS P30 DK035816NIGMS NIH HHS R01 GM131491NIGMS NIH HHS R01 GM138465
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Magnetic Resonance ImagingMetabolomicsMagnetic Resonance Spectroscopy

Identifiers

PMID36625102
PMCPMC9883114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.